抗原特異的規制ネットワークを拡張し,自己免疫を治療する
Xavier Clemente-Casares1, Jesus Blanco2,3, Poornima Ambalavanan1
1Julia McFarlane Diabetes Research Centre (JMDRC), and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
Nature
|February 18, 2016
まとめ
新しいナノ粒子薬は,自己免疫疾患を治療するために,抗原特異の調節性T細胞を体内で拡張します. これらの治療法は,疾患特有の治療アプローチを提供して,全体的な免疫に影響を与えることなく,既存の自己免疫状態を解決します.
科学分野:
- 免疫学
- ナノ医療
- 自己免疫 疾患
背景:
- 制御性T細胞は 自己免疫の管理に不可欠です
- 現在の方法では,抗原特異の調節性T細胞のインビボ拡張が欠けています.
- 自己免疫疾患の標的治療の開発は大きな課題です
研究 の 目的:
- ペプチドMHCクラスII (pMHCII) のナノ医薬品が抗原特異調節性T細胞をインビボで拡張する可能性を調査する.
- 確立された自己免疫疾患の治療効果を評価する.
- 免疫反応を調節するpMHCIIナノ医薬品のメカニズムを探求する.
主な方法:
- pMHCII分子に結合した自己免疫疾患に関連するペプチドでコーティングされたナノ粒子の全身輸送.
- 患者のリンパ球をヒト化したモデルも含む.
- CD4 ((+)) T細胞型1型 (TR1) 細胞の生成と増殖とその自己免疫現象への影響を評価した.
主要な成果:
- pMHCIIナノ医薬品は,抗原特異性TR1型細胞の生成と拡大を vivoで成功裏に誘発した.
- 既定の自己免疫疾患は,異なるマウスモデルで解消された.
- ナノ医薬品は,自己反応性T細胞のTR1型細胞への分化を引き起こし,抗原を提示する細胞を抑制し,全身免疫を損なうことなく,調節性B細胞の分化を促進した.
結論:
- pMHCIIベースのナノ医薬品は,自己免疫疾患に対する新しい治療法です.
- これらのナノ医薬品は,幅広い自己免疫疾患の治療に 疾患特有のアプローチを提供します.
- この発見は,抗原特異性調節性T細胞の in vivo 拡張のための有望な戦略を示しています.
関連する概念動画
Autoimmune Disorders
2.1K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
2.1K
T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
What is the Immune System?
145.7K
Overview
145.7K
Cell-mediated Immune Responses
86.0K
Overview
86.0K
Special Features of Adaptive Immunity
4.1K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
4.1K
Immune Response Against Viral Pathogens
2.5K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.5K


